Interpreting Abnormal SPEP – Is It Just MGUS?

About this episode

This episode discusses the interpretation of abnormal SPEP results and the clinical significance of MGUS.

Monoclonal gammopathy of undetermined significance (MGUS) is a common but often confusing finding on serum protein electrophoresis (SPEP) reports. In this HemeTalks episode, Drs. Rahma Warsame and Jason Chen discuss how to interpret abnormal SPEP results, evaluate patients with suspected MGUS, and differentiate between benign and concerning findings. Using real-world cases, they highlight key clinical decision points, follow-up strategies, and how to communicate results with patients effectively. Tune in for expert guidance on navigating this diagnostic gray zone in hematology. Learning Objectives: Recognize the clinical significance of MGUS and how it is detected Understand how to interpret MGUS lab testing results in the context of monoclonal gammopathies Identify when to refer, monitor, or investigate further in patients with MGUS Clinical Pearls: MGUS is a premalignant condition that is a diagnosis of exclusion. It is defined by the presence of a serum monoclonal protein (M-protein) less than 3 g/dL, bone marrow plasma cellsl <10%, and no end organ damage (CRAB) MGUS can progress to multiple myeloma, AL amyloidosis, Waldenstrom’s macroglobulinemia Confirmatory tests for…

People in this episode

Guests: Rahma Warsame, Jason Chen

Topics covered

• MGUS
• serum protein electrophoresis
• hematology
• clinical decision making
• patient communication

Keywords

• MGUS
• serum monoclonal protein
• bone marrow plasma cells
• multiple myeloma
• diagnostic gray zone

Mentioned in this episode

Organizations: American Society of Hematology

Books & works: Interpreting Abnormal SPEP – Is It Just MGUS?

More episodes of HemeTalks: Conversations in Hematology Education

• Re‑Thinking “Normal”: Absolute Neutrophil Count by Duffy Status · June 4, 2026 · 21 min
• Multiple Myeloma Care: Timing, Teamwork, Treatment · May 21, 2026 · 23 min
• Atención del Mieloma Múltiple: Oportunidad, Trabajo en Equipo y Tratamiento · May 21, 2026 · 22 min
• TTP Today: Diagnosis, Management & Evolving Therapies · May 7, 2026 · 20 min
• Approaching MDS: Advances in Diagnostics, Therapeutics and Monitoring · April 16, 2026 · 25 min
• New Horizons in Smoldering Multiple Myeloma · March 19, 2026 · 26 min